Precision for Value, an agency focused on demonstrating the value of medicines to payers, announced it will acquire Redwood Outcomes, a health economics and research firm.
Terms of the deal were not disclosed.
The move is meant to bolster the agency’s research capabilities by adding experience in epidemiology, statistics, meta-analysis, network meta-analysis and decision modeling. Precision for Value President Dan Renick said in a release, “Redwood Outcomes addresses the evolving and intensifying need for rigorous comparative and cost-effectiveness evidence of medical interventions to support healthcare and reimbursement decision-making.”
Redwood Outcomes was founded in 2013 and is headquartered in Vancouver, Canada.
Redwood will be folded into Precision Health Economics, which Precision for Value acquired in April. The agency also acquired a payer agency, Hobart Group Holdings, in 2013. Precision for Value is owned by Precision for Medicine.
